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The 3* noncoding region (3* NCR) of the hepatitis C virus (HCV) genome contained in viral particles was analyzed by an
RNA linker ligation followed by reverse transcription-polymerase chain reaction. Sequence analysis of the amplified fragment
from four strains, including different genotypes 1b, 2b, 3a, and 3b indicated that the 3* NCR is composed of between 200
and 235 nts. The sequence of the 3* NCR consists of a type-specific region (immediately following the termination codon),
a poly(U) stretch, a C(U)n-repeat, and highly conserved region termed the core element. The poly(U) stretch and C(U)n-
repeat regions varied in length and in sequence among different genotypes. Core elements having putative secondary
structure consisted of 98 or 100 nts and were highly conserved in all genotypes. Most of the nt changes found in different
genotypes did not affect the secondary structure of the core elements, suggesting that this region may play an important
role in replication, stabilization of the HCV RNA, and/or packaging of the genome. Most of the HCV-1b strains carried two
U residues at the 3* end of the core element, while the minor HCV-1b strains had no U residues, demonstrating that there
are two variants in type 1b strains. Amplification of the core element using linker-primed cDNA was comparable with that
using the 3* proximal core element-primed cDNA, indicating that the 3* end of HCV genome was terminated by an OH
group. q 1996 Academic Press, Inc.
5* NCR in both replication and polypeptide translationalHepatitis C virus (HCV) is the major causative agent
initiation (26). The polypyrimidine tract between nt 191of non-A, non-B hepatitis (5). It is an enveloped virus
and 199 is an important site for translation initiation andcontaining a positive strand RNA genome of approxi-
is the binding site for the cellular protein p89 (29).mately 9400 nucleotides (nt) in length. Its genome con-
sists of a relatively long (341-nt) 5* noncoding region (5* Contrary to the 5* NCR, the sequence of the 3*-NCR
NCR), a large open reading frame, which encodes 3010 consists of a short sequence (27–70 nt), which was
 3033 amino acid residues, and a short 3* NCR followed largely diversified among different genotypes, and a ho-
by a homopolymer tail of A (9) or U residues (6, 11, 14, mopolymer tail of U residues. Putative stem-loop struc-
27). By analogy with flaviviruses (4), this polypeptide can tures have been identified in the region both proximal
be divided into a 5* structural region consisting of the to the 3* end of the coding region and the 3* NCR of
putative core and envelope proteins and a 3* region cor- the genome in all HCV groups in spite of considerable
responding to nonstructural (NS1 to NS5) proteins. HCV primary sequence differences (10). Yoo et al. (30) trans-
shows substantial nt sequence diversity throughout the fected human hepatome cells with in vitro-transcribed
viral genome and has been classified into several geno- putative full-length cDNA. They apparently detected the
types to date (2, 19, 21). The 5* NCR is highly conserved replication of the transfected genome in cells, although
among all genotypes (3, 19) and it shares significant the 3* end of the transcribed RNA was terminated by
sequence and secondary structure homology with those either 15 U or 15 A residues, since the poly(U) tail was
of pestiviruses (1, 9), suggesting an important role for the believed to represent the 3*-terminus of the genome with
those of picornavirus (16).
Recently, Tanaka et al. (22) published information
1 Sequence data from this article have been deposited with the DDBJ/ about the sequence following the poly(U) tail of the 3*EMBL/GenBank databases under Accession No. D85016-85026.
terminus of the HCV type 1b genome. They synthesized2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 81-762-86-4693. a cDNA of negative strand genome RNA from a patient’s
255
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 8114 / 6a1d$$$541 08-05-96 08:51:16 viras AP: Virology
256 SHORT COMMUNICATION
liver followed by the addition of a poly(G) tail by terminal glycogen (Boeringer Manheim), and 25 ml ethanol. Li-
gated products were washed with 70% ethanol, prepre-transferase to assist the subsequent PCR. The longest
3* NCR comprising approximately 200 nt included a 98- cipitated, and dried at room temperature.
Ligation products were dissolved into 3 ml water andnt sequence with a putative stem-loop structure at the
3* end. They also determined the 3* NCR of type 2a converted into cDNA using 4 ng of primer #3*-4 (Table
1) and 100 U SuperScript II in a 10-ml solution volumegenome of the viral genome using an RNA ligation linker
method (23). following the manufacturer’s instructions (Gibco BRL).
Oligonucleotides used in this study are listed in TableTick borne encephalitis virus (TBEV), a family of Flavi-
viridae that is close to HCV, has a 3* NCR that varies in 1. PCR was run on at 947 for 1 min, 557 for 45 sec, and 697
for 1.5 min in first 2 cycles using Taq start (Stratagene) inlength from 350 to 750 nt. Wallner et al. (28) analyzed
the 3* end of various strains and showed that the size 12.5 ml volume followed by 907 for 1 min, 607 for 45 sec,
and 697 for 1.5 min with 48 cycles. Type 1b cDNAs wereheterogeneity was restricted to a variable region follow-
ing the termination codon, whereas the most 3*-terminal amplified with a primer set of type 1b-specific NS5B cod-
ing region #3*-1 and the linker region #3*-3. Type 2b100 nt form a highly conserved core element. In some
strains, e.g., Neudoerfl/263 and 132, the poly (A) stretch, cDNAs were amplified with a nested PCR using primer
set of type-specific NS5B region #3*-2 and the linker #3*-which is believed to be the 3*-terminus of the genome,
was found between the termination codon and the core 3 (first 35 cycles) and with a primer set of type-specific
TSR #3*-5 and the linker (#3*-3). The whole 3* NCR ofelement. Therefore, HCV and flavivirus genomes now
seem to share common sequence organization in the 3* HCV genomes with type 3a and type 3b could not be
amplified by any primers and any PCR conditions weNCR besides the coding region (4, 8). We describe here
the cloning of the 3* NCR compared between four HCV used. Therefore, PCR was carried out by dividing it into
two portions with 11 overlapping nts: one was the regionviral genome subtypes, the structural organization of the
3* NCR, and the 3*-terminus of the genome. between TSR and the 5* site of conserved region using
a primer set of #3*-17 and #3*-10 primers and the otherHCV samples were obtained from patients with
chronic hepatitis as follows; plasma samples 1257 (HCV- was the whole conserved region with the linker using a
primer set of #3*-11 and #3*-3. Southern blot analysis1b), 1509 (HCV-1b), and 4149 (HCV-1b) were obtained
from a Japanese patient, B15 (HCV-1b) and 42 (HCV-2b) was used to monitor whether or not the 3* NCR was
amplified and to estimate their sizes.from Brazilian patients, sample 865 (HCV-3a) from an
Australian patient that was previously reported (27), When RT-PCR products from four samples of type 1b
were analyzed by polyacrylamide gel electrophoresis fol-EM22 (HCV-3a) from a Spanish patient, and B1 (HCV-3b)
from a Bangladesh patient. Genotypes were determined lowed by Southern blot analysis using poly(A)30 as a
probe (15), fragments containing the homopolymer tail ofbased on the slot blot hybridization using type-specific
probe (21) and the sequence analysis of a portion of A or U residues were obtained as major products. These
fragments accompanied a substantial tailing backgroundNS5B regions (360 nt) including GDD motif (7, 13, 19).
RNA linker (GAUUGAGCAUCGAAUUCACGAUACUG- but their major bands were almost the same size with
260 nt in length. PCR products from samples 1509 andCCG-NH2) with an amino group at the 3* end was synthe-
sized with an ABI DNA synthesizer using phosphoramid- 4149 contained a minor component fragment which was
30–60 nt longer than the major component. Each bandites. Forty nanograms of the linker RNA was phosphory-
lated with 13 U of T4 polynucleotide kinase (Takara) in was excised and sequenced. Results are shown in Fig.
1. The major bands with 260 nt in length were composedthe presence of 0.5 mM RNase-free ATP (Boeringer Man-
heim) in 10-ml volume. RNA was prepared from 500 ml of the expected sequence of the type 1b-specific primer
(NS5B) followed by noncoding sequence (11, 24), homo-of plasma as previously described (7) and dissolved in
5 ml of diethylpyrocarbonate-treated water. To avoid a polymer stretch of U residues, CU or C(U)n-repeat re-
gions, and conserved region comprising 98 nt found bycontaminant RNase attack as much as possible, ligation
reaction was carried out under lower concentrations of Tanaka et al. (22). We designate this region as a core
element which was first proposed by Wallner et al. in theATP (1.5 mM), and shorter reaction time (1 hr) at 177 than
those of previous report (17). Under these conditions, 3* end of tick-borne encephalitis virus (28). These results
demonstrate that they were clearly derived from HCV-1b50–60% of the linker joined with the target RNA with only
a slight degradation of RNA. The ligation reaction was RNA due to the presence of the sequence between the
termination codon and the start position of the poly(U)carried out in a solution of 1.5 ml of RNA, 4 ng of phos-
phorylated RNA linker, 3.3 mM dithiothreitol, 1.5 mM ATP, stretch, which we named as a type-specific region in the
3* NCR (TSR). The core sequences were identical or12 U of RNase inhibitor (Takara), and 1 U of RNA ligase
(Takara) in 6 ml reaction volume at 177 for 1 hr. The almost identical except one nucleotide change to that
reported by Tanaka et al. (22). However, all these sam-ligation products were precipitated with ethanol after ad-
dition of 4 ml water, 1 ml of 2 M sodium acetate, 1 mg ples contained additional two U residues at the end of
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TABLE 1
Oligonucleotide Used in This Study









#3*-11 TTTTGGTGGCT CCATCTTAGCC 1b:CE:-4-18
#3*-12 TTAAGGTGGCTCCATCTTAGCC3* 3a, 3b CE:-4-18
#3*-17 TTAGGATCCATTTGCTGCTTTGCCTACTCCTACT 3a, 3b:9339-9365
#3*-31 AAACAGCTAGCCGTGAC CE:100-84
a The sequence numbers of 1b, 2b, and 3a are in the nucleotide sequences of HCV-J (11), HCV-J8 (14), and HCV-K3a/650 (27), respectively.
b CE is the core element.
the core element. Direct sequence analysis of PCR prod- variants in HCV-1b in regard to the 3* NCR. We tentatively
named each variant HCV-1b2U and HCV-1b0U, respec-ucts also showed the presence of two U residues at the
3* end. tively. Other variants of the core elements were also
found (nt change at position 65 or 83), but they seem toIn contrast to the 260-nt fragment, longer fragments
generated from type 1b samples did not have the two U be insignificant since these nt changes do not extend to
other regions. The nucleotide change from A to G residueresidues at the 3* end (Fig. 1). They differ in the 260-nt
fragment by slightly longer TSR comprising four or five at position 65 can still maintain the base-pair formation
with U residue (see Fig. 3), whereas the nucleotideC residues at its 3* end, long poly (U) stretch interrupted
by CCGC sequence and C residues, and no typical C(U)n- change from U to C residue at position 83 abolishes the
base-pair formation with A.repeat. These results demonstrate that there are two
FIG. 1. Nucleotide sequences of the 3* NCR of the HCV genome. Nucleotide sequences were shown by each genotype group and characteristic
regions such as TSR, the poly(U) stretch with a C(U)n-repeat regions, and the core elements. One or two major sequences from the PCR products
are listed in each sample. Nucleotides identical to representative sequence are depicted as horizontal bars and the gaps introduced for the
alignment are shown by skew bars. Sample numbers and their genotype are shown to the right. 2U and 0U in sample name indicate presence
and absence of two U residues at the 3* end, respectively.
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FIG. 2. Schematic representation of the predicted stem-loop structures within the core element found in the HCV-1b (left) and HCV-3b (right).
Substituted nts found in different genotypes are indicated by the arrow. Two U residues at the 3* end were found only in the HCV-RNA from major
type 1b strain. We termed three hair-pin stem-loop structures I, II, and III. The stem-loop II potentially forms an alternative structure II* which is
likely to exist in the HCV-3b-RNA.
Other isolates such as type 2a, 2b, 3a, and 3b were repeat, and the core element. Type 3b-derived sequence
showed several nt changes in the stem-loop III of thevery difficult to amplify by one-round PCR. After the sec-
ond round of the PCR, several products appeared from core element (see Fig. 2). The core sequence obtained
from two type 3a samples were the same as that of onetype 2a and type 2b samples. The sequence of cloned
cDNA of type 2b is shown in Fig. 1, which also contains of the three type 1b-2U. However, neither HCV-3a nor
HCV 3b genome contained extra U residues at theTSR of type 2b (14), homopolymer tail which was inter-
rupted by G residue, C(U)n-repeat, and the core element. 3* end.
In type 3b sequence a U-A pair replaced the A-U pairIn contrast to type 2b, all PCR products derived from type
2a RNA were not able to be cloned. Direct sequencing of type 1b keeping the free energy of stem-loop III. How-
ever, HCV-3a and -3b RNAs have the potential to form aanalysis indicated that the type 2a sequence was almost
identical to that reported by Tanaka et al. (23), short larger stem-loop I structure by the addition of four base-
pairs at the 3* end of the C(U)n-repeat region as shownpoly(U) stretch, C(U)n-repeat, and the same core element
as that of type 2b (data not shown). When the stems in Fig. 3b. If the stem-loop I is strengthened, the neigh-
boring stem structure is no longer a pair of the stem-were named, in order from 5* to 3*, I, II, and III, the
nucleotide changes were found only in stem-loop III (Fig. loop II due to the alternation of base pair partners. Thus,
two alternative structures are predicted with respect to2). We precisely analyzed the 3* end of type 2a and 2b,
but no additional U residue was found. middle stem loop, II or II* as illustrated in Fig. 2. The
failure of amplification of the whole 3* NCR from HCV-The whole 3* NCR of HCV-3a and HCV-3b genomes
could not be amplified by any of the primers and by any 3a and HCV-3b may attribute to a strong secondary struc-
ture of the core element.of the PCR conditions we used. Therefore, PCR of the 3*
NCR was carried out by dividing it into two portions with When comparing these four HCV-1b RNA, the length
of poly(U), the sequences of C(U)n-repeat and the core11 overlapping regions; one was from TSR (18, 25, 27)
to the 5* site of the core element and the second was sequence are similar to each other despite the fact that
these samples were collected from distant geographicalthe whole core element with the linker region. As shown
in Fig. 1, both consist of TSR, poly(U) stretch, C(U)n- regions and distinct from that of other isolates demon-
AID VY 8114 / 6a1d$$$542 08-05-96 08:51:16 viras AP: Virology
259SHORT COMMUNICATION
FIG. 3. Analysis of the 3* end of HCV genome. (A) Strategy of the experiments. After ligation of HCV-RNA and the linker RNA, cDNA was
synthesized from either proximal of the 3* end of the genomic region (#3*-31) or the linker site (#3*-4) and PCR of the core element was carried
out using primers #3*-11 and #3*-9. The ratio of the amplified fragment from the genome-primed cDNA and that from the linker primed cDNA would
estimate whether or not the 3* OH group of the HCV-RNA is free. (B) Southern blot analysis of PCR products of the core elements. cDNA was
synthesized from ligation products of HCV-RNA (from sample B15) and the linker RNA using the primer #3*-31 (left) or #3*-4 (right) followed by PCR
of the core element under the condition of 947 for 30 sec, 557 for 20 sec, and 727 for 10 sec, with 35 cycles in 50 ml reaction volume. The PCR
product was then divided into five equal portions (10 ml each) and was subjected to additional PCR with 1–5 cycles. Amplified fragments (2 ml)
were electrophoresed on 4% polyacrylamide gel, transferred on Hybond-N/ by alkali fixation method (15), and hybridized with 32P-labeled oligonucleo-
tide #3*-7. Lanes 1–5 are the product taken from cycles 40–36, respectively. (C) cDNA was also synthesized from nonligated HCV-RNA using the
primer #3*-31 (left) or #3*-4 (right) followed by PCR of the core element. (D) Plasmid containing the 3* NCR of sample at the EcoRV restriction
enzyme site of T7 Blue (Novagen) was digested with BamHI restriction enzyme and RNA was synthesized by T7 RNA polymerase. After treatment
with DNase I twice, RNA was diluted and used for cDNA synthesis using the primer #3*-31 (left) or #3*-4 (right) followed by PCR of the core element.
Lanes 1–5 are the products taken from cycles 35–31, respectively.
strating that these 3* NCR sequences are also useful for Although the results obtained above suggest the pres-
ence of an OH group at the 3* terminus, the question isgenotyping. It is noted that the sequence analysis of 10
clones obtained from 4149 (type 1b), 10 clones from 42 still needed to be addressed whether all of the 3* termi-
nus of the HCV genome carries a free OH group. The(type 2b), and 9 from EM22 (3a) represented a number of
different sequences in the poly(U) and the C(U)n-repeat possibility cannot be ruled out that the 3*-end was modi-
fied and only a small portion was cleaved at the se-regions; however, all clones seem to remain within the
range of their respective type. The length of homopoly- quence obtained above after the ligation reaction. There-
fore, we attempted a qualitative analysis of the efficiencymer was partly caused by PCR error, but variation of the
C(U)n-repeat region is not likely to be generated by PCR of the joining reaction between the linker RNA and the
HCV RNA using B15 sample (HCV-2U type). If there wereerror, because the cloned sequence is conserved during
PCR. These results suggest that the C(U)n-repeat region many unreacted HCV RNA as we expected, then the 3*
end of the HCV genome would be modified.is one of the most variable regions in the HCV genome.
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Figure 3A illustrates our strategy. After the joining reac- 1b2U genome primarily contains this sequence or
whether two extra U residues are added postreplica-tion between the linker RNA and the HCV RNA, the reac-
tion mixture was divided into two parts and cDNA was tionally. In all our tests thus far, neither type 1a nor type
2a RNA had an extra U residue at the 3* end.synthesized using two different primers; one annealed
with a linker site and the other annealed with a sequence Little is known about the function of the 3* NCR of
HCV genome. Yoo et al. (30) transfected human hepa-close to the 3* terminal end of the core element. PCR
was then carried out in the core element. If the 3* termi- tome cells (Huh7) with in vitro-transcribed HCV RNA that
carried a homopolymer tail of either A15 or U15 at thenus was modified, the overall yield of PCR product ob-
tained using the linker-primed cDNA should be less than 3* terminus and apparently succeeded the replication of
the transfected genome in cells. These results suggestthat obtained using the internally primed cDNA. Southern
blot analysis of the PCR products obtained after 36–40 a nonessential function for the C(U)n-repeat and the core
element in the replication process. However, high con-cycles from two different cDNAs (Fig. 3B) indicated that
the both PCR products were linearly increased as much servation of the primary and secondary structure of the
core elements and the presence of poly(U) stretch andas 40 cycles. However, the PCR product from internally
primed cDNA was a single component, whereas there C(U)n-repeat may play an important role in regulation of
replication and/or packaging process.were two components from the linker primed cDNA. No
PCR product was obtained when the linker-primed cDNA Biological functions of poly(U) stretch, C(U)n-repeat,
and the core elements remain to be elucidated.was synthesized before the ligation reaction (Fig. 3C).
Sequence analysis of these two amplified fragments re-
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